Historical record - last NADAC effective date: 10/21/2020
Product Information
ATORVASTATIN 10 MG TABLET is a generic product labeled by Cipla USA Inc., priced at $0.0519 per EA under NDC 69097089715. Its NADAC has been published 212 times since Oct 12, 2016.
FDA first approved this application on May 19, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ATORVASTATIN CALCIUM market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Cipla USA Inc.NDC
69097089715
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
10/21/2020
Active Ingredients
ATORVASTATIN CALCIUM TRIHYDRATEApproval Type
Generic (ANDA)
FDA Application
ANDA205519FDA Approved
5/19/2016
TE Code
AB
On Market Since
8/4/2016
Pharmacological Classes
Price Statistics
The NADAC for ATORVASTATIN 10 MG TABLET has been published 212 times since Oct 12, 2016, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0519 per EA |
|---|---|
| All-time high | $0.1049 (Jun 14, 2017) |
| All-time low | $0.0481 (Jul 22, 2020) |
| Median price | $0.0619 |
| Average price | $0.0662 |
| Largest weekly change | +25.3% (May 22, 2019) |
| Weeks tracked | 212 |
| Tracking since | Oct 12, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-41.5%
Last surveyed Oct 28, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 56% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ATORVASTATIN CALCIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
HMG-CoA Reductase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATORVASTATIN 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ATORVASTATIN 10 MG TABLET, manufactured by Cipla USA Inc., is $0.0519 per EA (NDC 69097089715), effective Oct 28, 2020.
How has the price of ATORVASTATIN 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for ATORVASTATIN 10 MG TABLET has declined 41.5%. It has been tracked across 212 weekly CMS publications since Oct 12, 2016.
What are the highest and lowest recorded NADAC prices for ATORVASTATIN 10 MG TABLET?
Since Oct 12, 2016, the NADAC for ATORVASTATIN 10 MG TABLET has ranged from a low of $0.0481 (Jul 22, 2020) to a high of $0.1049 (Jun 14, 2017), with a median of $0.0619 per EA.
Are there cheaper alternatives to ATORVASTATIN 10 MG TABLET?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATORVASTATIN 10 MG TABLET, is $0.0228 per EA — about 56% below ATORVASTATIN 10 MG TABLET.
Who manufactures ATORVASTATIN 10 MG TABLET?
ATORVASTATIN 10 MG TABLET (NDC 69097089715) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.